Wendy L. Dixon, Ph.D.
Dr. Dixon served as Chief Marketing Officer and President, Global Marketing for Bristol-Myers Squibb from 2001 to 2009. From 1996 to 2001 she was Senior Vice President, Marketing at Merck & Co. and prior to that she held executive management positions at West Pharmaceuticals, Osteotech and Centocor, as well as various positions at SmithKline and French (now GlaxoSmithKline) in marketing, regulatory affairs, project management and as a biochemist. In addition, Dr. Dixon was a Senior Advisor to The Monitor Group, now Deloitte, from 2010 to 2012. She is currently on the Boards of Directors of Incyte Corporation, bluebird bio, Inc. and Arvinas, Inc. Previously, Dr. Dixon served on the Boards of Directors of Dentsply International, Furiex Pharmaceuticals, Orexigen Therapeutics, Sesen Bio, Inc. (formerly Eleven Biotherapeutics, Inc.), Ardea Biosciences, Inc. and Voyager Therapeutics, Inc.
Back to Leadership page